Effect of SGLT2 inhibitor on lactic acid,ketone bodies,glucagon in type 2 diabetes mellitus patients

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: SGLT2 inhibitor CONDITION: type 2 diabetes mellitus PRIMARY OUTCOME: Change of serum lactic acid, ketone bodies,CPR,and glucagon value comparing with baseline. SECONDARY OUTCOME: Comparing with baseline change of urinalysis (sodium, potassium, glucose,osmotic pressure),uric acid,PRA,PAC,ACTH,cortisol,AVP,osmotic pressure. INCLUSION CRITERIA: 1)age 20 to less than 90. 2)ongoing treatment by sulfonylurea, biguanide, DPP4 inhibitor, thiazolidine, or insulin therapy.
Epistemonikos ID: e22bd68f11381485daa1c618284cd6e54b39c025
First added on: Aug 22, 2024